Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer

Name: Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer
License: Public Domain

Ruijin Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

muscle-invasive bladder carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 346933
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.